National Pension Service Acquires Shares of 900,000 Medline $MDLN

National Pension Service acquired a new stake in Medline (NASDAQ:MDLN) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 900,000 shares of the company’s stock, valued at approximately $37,800,000. National Pension Service owned approximately 0.07% of Medline at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Mass General Brigham Inc purchased a new stake in Medline in the 4th quarter valued at approximately $1,104,000. Baillie Gifford & Co. purchased a new stake in Medline in the 4th quarter valued at approximately $437,236,000. UBS Group AG purchased a new stake in Medline in the 4th quarter valued at approximately $54,707,000. Massachusetts Financial Services Co. MA purchased a new stake in Medline in the 4th quarter valued at approximately $429,544,000. Finally, Pictet Asset Management Holding SA purchased a new stake in Medline in the 4th quarter valued at approximately $48,996,000.

Medline Stock Performance

Shares of NASDAQ:MDLN opened at $36.56 on Monday. The stock’s 50 day moving average price is $42.30. Medline has a 12 month low of $34.89 and a 12 month high of $50.88.

Medline (NASDAQ:MDLN) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.29 by $0.04. The firm had revenue of $7.35 billion for the quarter. The business’s revenue for the quarter was up 10.7% on a year-over-year basis. Analysts expect that Medline will post 1.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on MDLN. Evercore reaffirmed an “outperform” rating and issued a $55.00 price objective on shares of Medline in a report on Wednesday, February 25th. Leerink Partners set a $56.00 price objective on Medline in a report on Wednesday, February 25th. BTIG Research reaffirmed a “buy” rating and issued a $55.00 price objective on shares of Medline in a report on Thursday, May 7th. Stifel Nicolaus set a $55.00 price target on Medline in a research note on Wednesday, February 25th. Finally, Citigroup decreased their price target on Medline from $60.00 to $55.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. Two analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Medline presently has an average rating of “Moderate Buy” and a consensus target price of $50.85.

Medline Profile

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.